一个新的管理严重的低衰减 传单加厚 继跨导管大动脉替换
Himax Patel1, John Lester2, Amr Essa1
1Department of Cardiology, Wellstar Medical College of Georgia Health Medical Center, Augusta, Georgia, USA.
Structural heart : the journal of the Heart Team
|September 25, 2025
概括
这项研究报告了组织等离子素激活剂 (tPA) 的首次使用,用于治疗跨导管大动脉置换后的低衰减叶片加厚 (HALT). 低剂量血栓溶解成功恢复了门功能,并解决了HALT.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 生物医学工程 生物医学工程
背景情况:
- 低衰减的叶片加厚 (HALT) 是通过导管的大动脉置换 (TAVR) 后的潜在并发症.
- 对于HALT的标准疗法并不总是有效的,需要使用替代治疗策略.
研究的目的:
- 报告第一次使用组织等离子体激活剂 (tPA) 治疗对标准治疗无反应的HALT.
- 评估低剂量血栓溶解在解决HALT和恢复TAVR功能的有效性和安全性.
主要方法:
- 在48小时内给予低剂量的组织等离子素激活剂 (tPA) 给TAVR后的HALT患者.
- 监测门功能和HALT分辨率.
- 使用计算机断层扫描血管学 (CTA) 确认HALT解析.
主要成果:
- 在低剂量血栓溶解后成功恢复TAVR门功能.
- 通过CTA确认HALT的完整解决方案.
- 在tPA服用期间或之后没有报告任何不良事件.
结论:
- 使用tPA的低剂量血栓溶解是一种可行且有效的治疗方法,用于对标准疗法耐药的TAVR后的HALT.
- 这种方法为管理HALT并确保TAVR长期耐用性提供了潜在的解决方案.
- 对HALT的tPA进行进一步调查是有必要的.
相关概念视频
Aortic Regurgitation III: Medical Management
397
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
397
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Mitral Valve Prolapse III: Nursing Management
291
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
291
Aortic Regurgitation IV: Nursing Management
280
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
280
Mitral Valve Prolapse II: Assessment and Management
425
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
425


